Fmoc-Abu(3-N3)-OH (2R,3R)

Fmoc-Abu(3-N3)-OH (2R,3R) is an Fmoc-protected, chiral amino acid derivative featuring an Abu (aminobutyric) backbone with a stereogenic pair at C2 and C3 and a side-chain azide substituent at the 3-position. The molecule contains the fluorenylmethoxycarbonyl (Fmoc) group on nitrogen, a free carboxylic acid for peptide coupling, and a pendant azide that functions as a chemically stable handle for orthogonal functionalization. The (2R,3R) configuration supports stereochemically defined incorporation into peptide sequences and can influence conformational preferences in short peptidomimetic scaffolds. The combination of an acid-bearing coupling site with an orthogonally reactive azide enables downstream derivatization while remaining compatible with protected amino acid synthesis and solid-phase peptide assembly workflows.

1. Peptide Synthesis

Fmoc-Abu(3-N3)-OH (2R,3R) is used as a protected amino acid building block for peptide coupling chemistry in automated solid-phase peptide synthesis and related chiral assembly strategies. The Fmoc-protected amine supports controlled N-deprotection cycles, while the free carboxylic acid enables amide bond formation to neighboring residues under standard peptide coupling conditions. The side-chain azide at the 3-position remains intact during typical Fmoc manipulations, allowing incorporation of a latent functional group directly into the peptide backbone. Resulting azide-bearing peptides can be further processed into functional analogs, including click-reactive conjugates and bioorthogonally addressable probes, supporting systematic peptide library construction and structure-defined scaffold generation.

2. Bioconjugation Chemistry

Fmoc-Abu(3-N3)-OH (2R,3R) serves as a chiral azide-bearing residue for chemical biology workflows that require orthogonal conjugation handles on peptide or protein-derived constructs. The pendant azide provides a reactive functional group for azide-alkyne cycloaddition or related azide-based ligation strategies, enabling site-selective attachment of labels, linkers, or affinity tags after peptide assembly. The stereodefined Abu side chain can help control local geometry around the conjugation site, which may affect labeling density, linker accessibility, and downstream binding behavior in biomolecule conjugates. The Fmoc-protected amino acid form facilitates incorporation into peptide carriers prior to conjugation, supporting modular design of bioconjugates and peptide-based chemical probes.

3. Peptidomimetics And SAR

Fmoc-Abu(3-N3)-OH (2R,3R) is applied in peptidomimetic construction and structure-activity relationship studies where stereochemistry and side-chain functionality must be encoded into the scaffold. The chiral (2R,3R) centers and the azide-bearing side chain allow synthesis of analog series that probe how stereodependence and functional-group placement influence target binding and recognition. The Fmoc-protected nitrogen and free acid enable systematic substitution into peptide-like backbones, supporting comparative studies across closely related analogs. The azide can be transformed into diverse substituents after scaffold assembly, enabling rapid generation of SAR-focused derivative sets from a common chiral intermediate.

4. Side-Chain Functionalization

Fmoc-Abu(3-N3)-OH (2R,3R) functions as a protected amino acid intermediate for post-assembly and late-stage side-chain modification strategies that rely on azide reactivity. The azide substituent at the 3-position can be converted into amines, triazoles, or other nitrogen-containing motifs depending on the chosen downstream transformation, while the peptide-compatible Fmoc/acid architecture supports its use as a coupling-ready precursor. The orthogonal nature of the azide relative to typical peptide protecting-group chemistries helps maintain the integrity of other functional groups during synthesis planning. Downstream conversion of the azide enables access to functionalized amino acid derivatives and labeled or reactive peptide analogs used in synthetic organic chemistry and biochemical research intermediate preparation.

5. Pharmaceutical Intermediate Preparation

Fmoc-Abu(3-N3)-OH (2R,3R) is suitable for process chemistry and fine chemical synthesis routes that require chiral, protected amino acid intermediates bearing orthogonally reactive handles. The Fmoc group provides a robust temporary protection strategy for the amino functionality, while the free carboxylic acid supports conversion into activated intermediates or direct incorporation into peptide fragments during manufacturing-oriented synthesis planning. The azide side chain can serve as a controlled precursor for downstream transformations that introduce functionality late in the synthetic sequence, supporting modular route design for complex chiral intermediates. The resulting derivatives can be employed as building blocks in the preparation of peptide-like intermediates, chiral fragment libraries, and manufacturable precursors for specialty chemical production.

1. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines